Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 49

1.

Letter: Modelling in Down Syndrome Screening.

Wyatt PR.

J Obstet Gynaecol Can. 2018 Mar;40(3):288-289. doi: 10.1016/j.jogc.2017.08.039. Epub 2017 Nov 10. No abstract available.

PMID:
29132965
2.

Investigation of NRXN1 deletions: clinical and molecular characterization.

Dabell MP, Rosenfeld JA, Bader P, Escobar LF, El-Khechen D, Vallee SE, Dinulos MB, Curry C, Fisher J, Tervo R, Hannibal MC, Siefkas K, Wyatt PR, Hughes L, Smith R, Ellingwood S, Lacassie Y, Stroud T, Farrell SA, Sanchez-Lara PA, Randolph LM, Niyazov D, Stevens CA, Schoonveld C, Skidmore D, MacKay S, Miles JH, Moodley M, Huillet A, Neill NJ, Ellison JW, Ballif BC, Shaffer LG.

Am J Med Genet A. 2013 Apr;161A(4):717-31. doi: 10.1002/ajmg.a.35780. Epub 2013 Mar 12.

PMID:
23495017
3.

Effect of mild hepatic or renal impairment on maternal serum screening biochemical measures.

Ying I, Wyatt PR, Nisenbaum R, Ray JG.

J Obstet Gynaecol Can. 2011 Dec;33(12):1218-1222. doi: 10.1016/S1701-2163(16)35105-2.

PMID:
22166275
4.

Refinement of the Region for Split Hand/Foot Malformation 5 on 2q31.1.

Theisen A, Rosenfeld JA, Shane K, McBride KL, Atkin JF, Gaba C, Hoo J, Kurczynski TW, Schnur RE, Coffey LB, Zackai EH, Schimmenti L, Friedman N, Zabukovec M, Ball S, Pagon R, Lucas A, Brasington CK, Spence JE, Sparks S, Banks V, Smith W, Friedberg T, Wyatt PR, Aust M, Tervo R, Crowley A, Skidmore D, Lamb AN, Ravnan B, Sahoo T, Schultz R, Torchia BS, Sgro M, Chitayat D, Shaffer LG.

Mol Syndromol. 2010;1(5):262-271. Epub 2011 May 18.

5.

Maternal obesity and the risk of placental vascular disease.

Becker T, Vermeulen MJ, Wyatt PR, Meier C, Ray JG.

J Obstet Gynaecol Can. 2008 Dec;30(12):1132-1136. doi: 10.1016/S1701-2163(16)34023-3.

PMID:
19175965
6.

Fragile X testing in obstetrics and gynaecology in Canada.

Chitayat D, Wyatt PR; SOCIETY OF OBSTETRICIANS AND GYNAECOLOGISTS OF CANADA GENETICS COMMITTEE; CANADIAN COLLEGE OF MEDICAL GENETICISTS PRENATAL DIAGNOSIS COMMITTEE.

J Obstet Gynaecol Can. 2008 Sep;30(9):837-841. doi: 10.1016/S1701-2163(16)32949-8. English, French.

PMID:
18845054
7.

Optimizing risk reduction in screening for Down syndrome.

Wyatt PR.

Prenat Diagn. 2007 Dec;27(13):1268. No abstract available.

PMID:
18046735
8.

Metabolic syndrome features and risk of neural tube defects.

Ray JG, Thompson MD, Vermeulen MJ, Meier C, Wyatt PR, Wong PY, Summers AM, Farrell SA, Cole DE.

BMC Pregnancy Childbirth. 2007 Sep 19;7:21.

9.

Prepregnancy diabetes and risk of placental vascular disease.

Becker T, Vermeulen MJ, Wyatt PR, Meier C, Ray JG.

Diabetes Care. 2007 Oct;30(10):2496-8. Epub 2007 Jun 22. No abstract available.

PMID:
17586740
10.

Vitamin B12 and the risk of neural tube defects in a folic-acid-fortified population.

Ray JG, Wyatt PR, Thompson MD, Vermeulen MJ, Meier C, Wong PY, Farrell SA, Cole DE.

Epidemiology. 2007 May;18(3):362-6.

PMID:
17474166
11.

Expectations of care in different practice jurisdictions.

Wyatt PR.

Prenat Diagn. 2007 May;27(5):485. No abstract available.

PMID:
17471608
12.

Trends in obesity in pregnancy.

Ray JG, Nisenbaum R, Singh G, Meier C, Guerin A, Wyatt PR, Vermeulen MJ.

Epidemiology. 2007 Mar;18(2):280-1. No abstract available.

PMID:
17301710
13.

The identification of risk of spontaneous fetal loss through second-trimester maternal serum screening.

Huang T, Owolabi T, Summers AM, Meier C, Wyatt PR.

Am J Obstet Gynecol. 2005 Aug;193(2):395-403.

PMID:
16098861
14.

Greater maternal weight and the ongoing risk of neural tube defects after folic acid flour fortification.

Ray JG, Wyatt PR, Vermeulen MJ, Meier C, Cole DE.

Obstet Gynecol. 2005 Feb;105(2):261-5.

PMID:
15684149
15.

Age-specific risk of fetal loss observed in a second trimester serum screening population.

Wyatt PR, Owolabi T, Meier C, Huang T.

Am J Obstet Gynecol. 2005 Jan;192(1):240-6.

PMID:
15672031
16.
17.

Maternal ethnicity and risk of neural tube defects: a population-based study.

Ray JG, Vermeulen MJ, Meier C, Cole DE, Wyatt PR.

CMAJ. 2004 Aug 17;171(4):343-5.

18.

Association between folic acid food fortification and congenital orofacial clefts.

Ray JG, Meier C, Vermeulen MJ, Wyatt PR, Cole DE.

J Pediatr. 2003 Dec;143(6):805-7.

PMID:
14657833
19.

Maternal serum screening in Ontario using the triple marker test.

Summers AM, Farrell SA, Huang T, Meier C, Wyatt PR.

J Med Screen. 2003;10(3):107-11.

PMID:
14561260
20.

Prevalence of trisomy 21 following folic acid food fortification.

Ray JG, Meier C, Vermeulen MJ, Cole DE, Wyatt PR.

Am J Med Genet A. 2003 Jul 30;120A(3):309-13.

PMID:
12838547
21.

Accuracy of trisomy 18 screening using the second-trimester triple test.

Meier C, Huang T, Wyatt PR, Summers AM.

Prenat Diagn. 2003 Jun;23(6):443-6.

PMID:
12813756
22.

The implications of a false positive second-trimester serum screen for Down syndrome.

Summers AM, Huang T, Meier C, Wyatt PR.

Obstet Gynecol. 2003 Jun;101(6):1301-6.

PMID:
12798540
23.

Maternal serum marker medians in Aboriginal Canadian women.

Huang T, Summers AM, Wyatt PR, Meier C, Côté GB.

Prenat Diagn. 2003 Feb;23(2):98-100.

PMID:
12575012
24.
25.

Association of neural tube defects and folic acid food fortification in Canada.

Ray JG, Meier C, Vermeulen MJ, Boss S, Wyatt PR, Cole DE.

Lancet. 2002 Dec 21-28;360(9350):2047-8.

PMID:
12504403
26.
27.

Bibliography. Current awareness in prenatal diagnosis.

Summers AM, Huang T, Wyatt PR.

Prenat Diagn. 2002 Mar;22(3):272-8. No abstract available.

PMID:
11920910
28.

Pregnancy outcomes of women with positive serum screening results for Down syndrome and trisomy 18.

Summers AM, Huang T, Wyatt PR.

Prenat Diagn. 2002 Mar;22(3):269-71. No abstract available.

PMID:
11920909
29.

Accuracy of expected risk of Down syndrome using the second-trimester triple test.

Meier C, Huang T, Wyatt PR, Summers AM.

Clin Chem. 2002;48(4):653-5. No abstract available.

30.

Ongoing surveillance for neural tube defects and Down syndrome in a large urban maternal newborn hospital.

Wyatt PR, Summers AM, Dimnik G, Pollard B, Shilletto N.

Ann N Y Acad Sci. 1998 Jun 18;847:252-4. No abstract available.

PMID:
9668722
31.

Triple-marker screening for Down syndrome.

Farrell SA, Chadwick DE, Summers AM, Wyatt PR.

CMAJ. 1996 Aug 1;155(3):271-2; author reply 272-3. No abstract available.

32.

Preconception clinical genetics.

Wyatt PR.

Can Fam Physician. 1988 Apr;34:891-3.

33.

The "new genetics".

Meschino WS, Wyatt PR.

Can Fam Physician. 1988 Apr;34:769-81. English, French. No abstract available.

34.

Pallister-Killian syndrome--an update of a clinical case.

Wyatt PR.

Am J Med Genet. 1988 Jan;29(1):229. No abstract available.

PMID:
3344773
35.

Chorionic biopsy and increased anxiety.

Wyatt PR.

Lancet. 1985 Dec 7;2(8467):1312-3. No abstract available.

PMID:
2866382
36.

Screening for Down's syndrome using alpha fetoprotein.

Wyatt PR.

Br Med J (Clin Res Ed). 1985 Sep 14;291(6497):740. No abstract available.

37.

Prenatal diagnosis of tetrasomy 21.

Lopes V, Mak E, Wyatt PR.

Prenat Diagn. 1985 May-Jun;5(3):233-5.

PMID:
3161017
38.

The place of chorionic biopsy.

Wyatt PR.

Lancet. 1983 Oct 8;2(8354):847. No abstract available.

PMID:
6137667
39.

Should screening programs be perfect?

Wyatt PR.

Pediatrics. 1983 Feb;71(2):301. No abstract available.

PMID:
6823445
40.

Issues surrounding genetic screening programs.

Wyatt PR.

Am J Public Health. 1981 Dec;71(12):1411. No abstract available.

41.

Prenatal diagnosis.

Wyatt PR.

N Engl J Med. 1979 Jun 7;300(23):1339. No abstract available.

PMID:
440349
42.

Tay-Sachs disease: ultrastructural studies on cultured fibroblasts.

Wyatt PR, Cox DM, Hoogstraten J.

Pediatr Res. 1978 Apr;12(4 Pt 1):310-3.

PMID:
652414
43.

Who's for amniocentesis.

Wyatt PR.

Lancet. 1977 Jun 18;1(8025):1315. No abstract available.

PMID:
68416
44.

Duchenne's muscular dystrophy: studies in cultured fibroblasts.

Wyatt PR, Cox DM.

Lancet. 1977 Jan 22;1(8004):172-4.

PMID:
64702
45.
46.

John Humphrey Noyes and the stirpicultural experiment.

Wyatt PR.

J Hist Med Allied Sci. 1976 Jan;31(1):55-66.

PMID:
770565
47.

Letter: Illustrating cretinism.

Wyatt PR.

Lancet. 1974 Nov 9;2(7889):1151. No abstract available.

PMID:
4139458
48.

Letter: Stopping smoking after myocardial infarction.

Wyatt PR.

Lancet. 1974 Mar 30;1(7857):558. No abstract available.

PMID:
4131988
49.

Letter: Prenatal treatment of hereditary diseases?

Wyatt PR.

Lancet. 1973 Nov 3;302(7836):1027. No abstract available.

PMID:
4127249

Supplemental Content

Loading ...
Support Center